The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST
Health Status Indicators
Tissue Plasminogen Activator
The THRIVE score predicts the risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator administration. This external validation of the relationship between THRIVE and symptomatic intracranial hemorrhage in a prospective study further strengthens the role of the THRIVE score in the prediction of poststroke outcomes.